Insulet (PODD) Accounts Payables (2010 - 2026)
Insulet's (PODD) quarterly Accounts Payables came in at $149.8 million in Q1 2026, up 160.07% YoY from $57.6 million in Q1 2025, and up 99.73% on a QoQ basis from $75.0 million in Q4 2025.
Insulet (PODD) Accounts Payables (2010 - 2026) Analysis & Trends
Insulet (PODD) has 17 years of Accounts Payables data on file, last reported at $149.8 million in Q1 2026.
- Quarterly Accounts Payables rose 160.07% year-over-year to $149.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $149.8 million (up 160.07% YoY) and the FY2025 annual result came in at $75.0 million, up 278.79% from the prior year.
- Accounts Payables advanced to $149.8 million in Q1 2026, from $75.0 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $149.8 million in Q1 2026 to a low of $19.2 million in Q4 2023.
- A 5-year average of $66.6 million and a median of $62.1 million in 2022 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2024 — Accounts Payables slumped 48.2% — and 2025, when it surged 278.79%.
- Tracing PODD's Accounts Payables over 5 years: stood at $30.8 million in 2022, then plunged by 37.66% to $19.2 million in 2023, then advanced by 3.12% to $19.8 million in 2024, then surged by 278.79% to $75.0 million in 2025, then surged by 99.73% to $149.8 million in 2026.
- The last three Accounts Payables figures came in at $149.8 million (Q1 2026), $75.0 million (Q4 2025), and $48.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 4.79 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 1.23 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 210.50 Mn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 3.23 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 2.42 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 344.10 Mn |
| 10 | Insulet | 10.36 Bn | 9.82 Bn | 562.60 Mn | 123.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 123.30 Mn |
| Mar 31, 2026 | 149.80 Mn |
| Dec 31, 2025 | 75.00 Mn |
| Sep 30, 2025 | 48.20 Mn |
| Jun 30, 2025 | 96.10 Mn |
| Mar 31, 2025 | 57.60 Mn |
| Dec 31, 2024 | 19.80 Mn |
| Sep 30, 2024 | 40.30 Mn |
| Jun 30, 2024 | 76.80 Mn |
| Mar 31, 2024 | 75.90 Mn |
| Dec 31, 2023 | 19.20 Mn |
| Sep 30, 2023 | 77.80 Mn |
| Jun 30, 2023 | 107.50 Mn |
| Mar 31, 2023 | 85.90 Mn |
| Dec 31, 2022 | 30.80 Mn |
| Sep 30, 2022 | 62.10 Mn |
| Jun 30, 2022 | 57.20 Mn |
| Mar 31, 2022 | 52.20 Mn |
| Dec 31, 2021 | 37.70 Mn |
| Sep 30, 2021 | 58.00 Mn |